Hosted on MSN43m
Aethlon Medical treats first subject with Hemopurifier device in Australia
US-based Aethlon Medical has treated the first subject with its Hemopurifier investigational device in its Australian cancer ...
Zacks Small Cap Research on MSN6h
AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier
AEMD Aethlon Medical (NASDAQ:AEMD) announced that the first patient in its Australian safety, feasibility and dose-finding clinical trial has been treated with the Hemopurifier. The trial is designed ...
'Huge relief' as teen rings cancer-free bell
Dan Evans, 19, from Newark in Nottinghamshire, described his huge relief ringing the "cancer-free bell" at the teenage cancer ...
appliedclinicaltrialsonline7h
Merck Stops HYPERION Trial for Winrevair in PAH Following Positive ZENITH Trial Results
The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the efficacy of Winrevair (sotatercept-csrk) in treating pulmonary arterial ...